* Consumer awareness and cultural barriers surrounding screening putting lives at risk
* 15 million years of 'healthy life' were lost worldwide in 2008 due to women dying early or being ill with the disease
Chalfont St. Giles, U.K. --- October 15, 2013. Rising breast cancer incidence and mortality represent a significant and growing threat for the developing world, according to a new global study commissioned by GE Healthcare.
MILWAUKEE - GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 "Image of the Year."
Professor Flamen's winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.
WAUKESHA, WI -- July 30, 2013-- GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval application (PMA[1]) for GE Breast Tomosynthesis, an option of the Senographe* Essential system.
Family support more influential than public health campaigns and celebrity diets when trying to kick bad habits and lead a healthier lifestyle
Chalfont St. Giles, UK; June 26, 2013: New research commissioned by GE Healthcare, undertaken by TNS in eight countries1 last month, has revealed that adults are unaware of the link between bad habits such as smoking, excessive alcohol consumption or physical inactivity and breast cancer.
